As such, the mechanism of action of GR agonists in asthma is nonspecific and impacts a wide variety of cells within the airways to suppress airway inflammation, prevent the recruitment of inflammatory cells to the airways, and indirectly promote the relaxation of smooth muscles [6,7,8]. The gene discussed is NR3C1; the disease is asthma.